Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free COCH Stock Alerts

Envoy Medical (COCH) Competitors

Envoy Medical logo
$0.71 -0.02 (-2.75%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 +0.01 (+0.70%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

COCH vs. VANI, PDEX, ZJYL, FOCL, and KRMD

Should you buy Envoy Medical stock or one of its competitors? Envoy Medical's main competitors and comparable companies include Vivani Medical (VANI), Pro-Dex (PDEX), Jin Medical International (ZJYL), FocalTherics (FOCL), and KORU Medical Systems (KRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Envoy Medical compare to Vivani Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, Vivani Medical had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for Vivani Medical and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat Vivani Medical's score of 0.83 indicating that Envoy Medical is being referred to more favorably in the media.

Company Overall Sentiment
Envoy Medical Very Positive
Vivani Medical Positive

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 7.2% of Envoy Medical shares are held by company insiders. Comparatively, 53.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Envoy Medical presently has a consensus price target of $2.00, suggesting a potential upside of 181.69%. Vivani Medical has a consensus price target of $3.75, suggesting a potential upside of 204.88%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts clearly believe Vivani Medical is more favorable than Envoy Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Vivani Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$240K228.35-$23.76M-$0.76N/A
Vivani MedicalN/AN/A-$26.61M-$0.35N/A

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-11,304.83% N/A -144.13%
Vivani Medical N/A -191.05%-70.91%

Envoy Medical has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.36, meaning that its share price is 136% more volatile than the broader market.

Summary

Vivani Medical beats Envoy Medical on 9 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Pro-Dex presently has a consensus target price of $74.00, suggesting a potential upside of 10.60%. Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 181.69%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Pro-Dex had 11 more articles in the media than Envoy Medical. MarketBeat recorded 12 mentions for Pro-Dex and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat Pro-Dex's score of 0.67 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Pro-Dex Positive
Envoy Medical Very Positive

Pro-Dex has a net margin of 17.62% compared to Envoy Medical's net margin of -11,304.83%. Pro-Dex's return on equity of 25.13% beat Envoy Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex17.62% 25.13% 16.02%
Envoy Medical -11,304.83%N/A -144.13%

Pro-Dex has a beta of 0.06, meaning that its stock price is 94% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market.

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$77.55M2.76$13.66M$4.1316.20
Envoy Medical$240K228.35-$23.76M-$0.76N/A

Summary

Pro-Dex beats Envoy Medical on 12 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Envoy Medical has a consensus target price of $2.00, suggesting a potential upside of 181.69%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Jin Medical International has higher revenue and earnings than Envoy Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M7.54$1.19MN/AN/A
Envoy Medical$240K228.35-$23.76M-$0.76N/A

In the previous week, Jin Medical International had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for Jin Medical International and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat Jin Medical International's score of 0.77 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Positive
Envoy Medical Very Positive

8.6% of Envoy Medical shares are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Jin Medical International has a beta of 7.31, suggesting that its stock price is 631% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Envoy Medical -11,304.83%N/A -144.13%

Summary

Envoy Medical beats Jin Medical International on 7 of the 13 factors compared between the two stocks.

How does Envoy Medical compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by company insiders. Comparatively, 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

FocalTherics has a net margin of -56.26% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
FocalTherics-56.26% -248.00% -44.69%
Envoy Medical -11,304.83%N/A -144.13%

FocalTherics currently has a consensus price target of $7.75, suggesting a potential upside of 89.95%. Envoy Medical has a consensus price target of $2.00, suggesting a potential upside of 181.69%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than FocalTherics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FocalTherics
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

FocalTherics has a beta of -0.07, indicating that its share price is 107% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market.

Envoy Medical has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FocalTherics$79.31M1.93-$29.25M-$1.03N/A
Envoy Medical$240K228.35-$23.76M-$0.76N/A

In the previous week, FocalTherics had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for FocalTherics and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat FocalTherics' score of 0.96 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Overall Sentiment
FocalTherics Positive
Envoy Medical Very Positive

Summary

FocalTherics and Envoy Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

Envoy Medical (NASDAQ:COCH) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

KORU Medical Systems has a net margin of -4.03% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-11,304.83% N/A -144.13%
KORU Medical Systems -4.03%-10.63%-6.51%

Envoy Medical presently has a consensus price target of $2.00, suggesting a potential upside of 181.69%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 121.52%. Given Envoy Medical's higher probable upside, research analysts plainly believe Envoy Medical is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, KORU Medical Systems had 4 more articles in the media than Envoy Medical. MarketBeat recorded 5 mentions for KORU Medical Systems and 1 mentions for Envoy Medical. KORU Medical Systems' average media sentiment score of 1.90 beat Envoy Medical's score of 1.89 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Overall Sentiment
Envoy Medical Very Positive
KORU Medical Systems Very Positive

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Envoy Medical has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$240K228.35-$23.76M-$0.76N/A
KORU Medical Systems$41.13M3.53-$2.64M-$0.04N/A

Summary

KORU Medical Systems beats Envoy Medical on 11 of the 16 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCH vs. The Competition

Export
MetricEnvoy MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$54.81M$5.42B$7.16B$14.34B
Dividend YieldN/A1.80%2.57%11.71%
P/E Ratio-0.9325.06273.4125.34
Price / Sales228.3583.63674.9298.63
Price / CashN/A33.0328.4234.96
Price / Book-1.695.9910.386.20
Net Income-$23.76M$150.13M$3.49B$358.18M
7 Day Performance-0.15%-2.23%-2.20%-1.61%
1 Month Performance-11.25%-3.84%-0.38%-3.62%
1 Year Performance-46.62%10.26%19.16%5.95%

Envoy Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCH
Envoy Medical
2.6621 of 5 stars		$0.71
-2.8%		$2.00
+181.7%		-43.4%$54.81M$240KN/A34
VANI
Vivani Medical
4.0863 of 5 stars		$1.32
-3.0%		$3.75
+185.2%		+4.1%$118.62MN/AN/A20
PDEX
Pro-Dex
2.74 of 5 stars		$60.70
-8.6%		$70.00
+15.3%		+101.3%$194.24M$77.55M14.70140
ZJYL
Jin Medical International
1.0771 of 5 stars		$2.25
+11.4%		N/A-84.4%$176.47M$20.69MN/A245
FOCL
FocalTherics
4.2055 of 5 stars		$4.20
-0.2%		$7.75
+84.5%		N/A$157.62M$79.31MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel